Helen of Troy Limited reported unaudited consolidated financial results for the third quarter and nine month periods ended November 30, 2012. Fiscal 2013 third quarter net sales revenue was $374,599,000 compared to $338,785,000 in the same period of the prior year, an increase of $35,814,000, or 10.6%. Net income for the third quarter of fiscal 2013 was $37,719,000, or $1.18 per fully diluted share, compared to $32,879,000, or $1.04 per fully diluted share, in the prior year third quarter, an increase in net income of $4,840,000 or 14.7%. Operating income for the third quarter of fiscal 2013 was a record $47,052,000 compared to $41,828,000 in the same period last year, an increase of $5,224,000, or 12.5%. Income before income taxes was $43.804 million against $39.06 million for the same period of last year. EBITDA was $55.819 million against $49.308 million for the same period of last year.

Net sales revenue for the nine months ended November 30, 2012 was $962,221,000 versus net sales revenue of $887,672,000 in the same period of the prior year, an increase of $74,549,000, or 8.4%. For the nine month period ended November 30, 2012, net income was $84,159,000, or $2.64 per fully diluted share, compared to $81,077,000, or $2.56 per fully diluted share, in the same period last year, an increase in net income of $3,082,000 or 3.8%. Operating income for the nine month period ended November 30, 2012 was a record $109,041,000 compared to $102,831,000 in the same period last year, an increase of $6,210,000, or 6.0%. EBITDA without share-based compensation for the third quarter of fiscal 2013 was $57,107,000 compared to $50,376,000 in the same period last year, an increase of $6,731,000, or 13.4%. EBITDA without share-based compensation for the nine month period ended November 30, 2012 was $140,032,000 compared to $125,524,000 in the same period last year, an increase of $14,508,000, or 11.6%. Income before income taxes was $99.405 million against $92.854 million for the same period of last year. EBITDA was $135.615 million against $123,293 million for the same period of last year. Capex was $6.4 million.

The company still expect earnings per fully diluted share for the full year to be in the range of $3.50 to $3.60, the company now expect net sales revenue to be in the range of $1,275,000,000 to $1.3 billion.